Empyrean Capital Partners’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

Empyrean Capital Partners’s Portfolio HCAQ Stock Details HCAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-197,791	Closed	-$1.96M	–	204
2021 Q3	$1.96M	Sell	197,791 -2,160	-1%	-$21.4K	0.04%	140
2021 Q2	$1.97M	Buy	+199,951	New	+$1.98M	0.05%	151

Empyrean Capital Partners's HCAQ Position: Q4 2021 in Review

Empyrean Capital Partners sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q4 2021, closing a stake of 197,791 shares — an estimated $1.96M sold.

Empyrean Capital Partners first reported a position in HCAQ in Q2 2021 and held it in 2 quarters. The position peaked at $1.97M in Q2 2021. 0 funds tracked by Wall St. Rank hold HCAQ as of Q4 2021.

Empyrean Capital Partners reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
Empyrean Capital Partners sold 197,791 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q4 2021, an estimated $1.96M.
Empyrean Capital Partners first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 2 quarters.
Empyrean Capital Partners's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $1.97M in Q2 2021.
0 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q4 2021.

Based on Empyrean Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.